基于碳硫模块平衡策略的大肠杆菌高产L-半胱氨酸菌株构建

l-半胱氨酸是一种重要的含硫氨基酸,因其多样的生理功能,l-半胱氨酸在医药、化妆品和食品工业中有着广泛的应用。模块化代谢工程策略在细胞工厂的构建中具有极大的潜力。本研究利用碳硫模块协同表达策略进行大肠杆菌的l-半胱氨酸合成途径构建,构建了一株l-半胱氨酸合成基因工程菌。首先,通过增强l-半胱氨酸前体物质l-丝氨酸(serA^f、serB和serC^Cg)的生物合成以及转录调控因子CysB的表达,l-半胱氨酸的产量由0提高到(0.38±0.02)g/L。然后,通过促进l-半胱氨酸转运和无机硫源的吸收同化、减弱l-半胱氨酸和l-丝氨酸的降解以及异源表达cysE^f和cysB^St,l-半胱氨酸的产量提升至(3.82±0.01)g/L。最后,为了优化碳模块和硫模块的代谢通量,协同表达硫酸盐同化途径与硫代硫酸盐同化途径的基因cysM、nrdH、cysK以及cysIJ,得到l-半胱氨酸高产菌株。在500mL摇瓶和2L发酵罐中分别实现了(4.17±0.07)g/L和(11.94±0.1)g/L的l-半胱氨酸积累。研究结果表明,在细胞内通过对硫碳模块间代谢通量的协调控制,可以实现l-半胱氨酸的高效生物合成。研究结果为微生物发酵生产l-半胱氨酸的产业化奠定了基础。     

代谢工程改造大肠杆菌合成己二酸

己二酸是一种具有重要应用价值的二元羧酸,是合成尼龙-66的关键前体。目前,生物法生产己二酸存在生产周期长、生产效率低的问题。本研究选择一株野生型高产琥珀酸菌株大肠杆菌(Escherichia coli) FMME N-2为底盘细胞,首先通过引入逆己二酸降解途径的关键酶,成功构建了可合成0.34 g/L己二酸的E. coli JL00菌株;接着,对合成路径限速酶进行表达优化,使E. coli JL01菌株在摇瓶发酵条件下产量达到0.87 g/L;随后,通过敲除sucD基因、过表达acs基因和突变lpd基因的组合策略平衡己二酸合成前体的供应,优化菌株E. coli JL12己二酸产量进一步提升至1.51 g/L;最后,在5 L发酵罐上对己二酸发酵工艺进行优化。工程菌株经72 h分批补料发酵,己二酸的产量达到22.3 g/L,转化率为0.25 g/g,生产强度为0.31 g/(L·h),具备了一定的应用潜力。本研究可为包括己二酸在内的多种二元羧酸细胞工厂的构建提供理论依据和技术基础。     

头状轮生链霉菌芳香族氨基酸合成途径的调节

对头状轮生链霉菌(Streptoverticillium caespitosus)芳香氨基酸合成途径的研究表明,第一个酶即3—脱氧—α—阿拉伯庚酮糖-7-磷酸(DAHP)合成酶无同工酶,不被L-色氨酸阻遏,比活力可被硝酸盐促进。L-色氨酸强烈地反馈抑制此酶,L-酪氨酸和L-苯丙氨酸无作用。L-色氨酸的反馈抑制对磷酸烯醇式丙酮酸(PEP)是非竞争性的,K_I为373μmol/L。酶对PEP和4-磷酸亦藓糖(E4P)的K_m值分别为50和100μmol/L。PEP和C0²⁺对酶有稳定作用。邻氨基苯甲酸合成酶活力可被1mmol/L L-色氨酸完全抑制,此酶也受L-色氨酸的阻遏,但是色氨酸支路上其余4个酶不被阻遏。分支酸变位酶被L-酪氨酸抑制。L-苯丙氨酸抑制预苯酸脱水酶,并更强地抑制预苯酸脱氢酶。     

NH4+对L-色氨酸发酵的影响

目的:探究NH₄⁺浓度对大肠杆菌E.coli TRTH发酵生产L-色氨酸的影响。方法:通过外源添加试验,利用30 L发酵罐进行分批补料发酵试验,考察E. coli TRTH发酵生产L-色氨酸过程中生物量、L-色氨酸产量、有机酸含量、耗糖速率、发酵液中NH₄⁺浓度及质粒稳定性变化。建立了大肠杆菌合成L-色氨酸的代谢流平衡模型,应用 MATLAB 软件计算出E. coli TRTH发酵中后期代谢网络的代谢流分布。结果:发酵结果显示,利用NaOH和氨水混合补料,控制NH₄⁺浓度在120 mmol/L以下,菌体能够以较长时间和较高比生长速率保持对数生长,最终菌体生物量和L-色氨酸产量分别提高了12.16%和19.80%。随着NH₄⁺浓度的增加,发酵液中丙酮酸、乳酸及乙酸浓度均略有增加,细胞质粒稳定性下降。控制NH₄⁺浓度在120 mmol/L以下,E. coli TRTH发酵生产L-色氨酸的代谢流量分析结果表明,EMP途径的代谢流量降低7.31%,PP途径的代谢流量增加7.14%,TCA循环的代谢流量降低22.04%。结论:高浓度的NH₄⁺导致菌体生长提前结束,耗糖速率降低,产酸受阻,控制NH₄⁺浓度在120 mmol/L以下,解除了NH₄⁺对菌体生长和产物生成的抑制,使得菌体生物量和L-色氨酸产量大幅提高,实现了高密度发酵培养的目的。     

L-苹果酸产生菌筛选及高产突变株诱变选育

通过广泛收集和分离,获得根霉属(Rhizopus)、曲霉属(Aspergillus)及裂褶菌属(Schizophyllum)等属菌株897株。产酸指示平板上的变色圈测定结果表明,它们中间628株为产酸菌。通过纸层析对产酸菌发酵液酸谱的分析,获得129株L-苹果酸产生菌,经进一步测定发酵液中L-苹果酸的含量,筛选出以葡萄糖为原料,摇瓶发酵140小时,L-苹果酸产率48．37g／L,对糖转化率48．37×10^-2 的菌株LMO2。经初步鉴定,这一菌株为曲霉(Asper-gillus sp.)以LM02作为出发株,采用亚硝基胍、自然污染细菌、甲基磺酸乙酯及紫外线进行诱变处理,选育出葡萄糖为原料,L-苹果酸产率较高的突变抹N1-14、N1-14、NE1412、NU1416及NU1419。其中N1-14 的L-苹果酸产量最高,比出发株提高46．2×10^-2。N1-14 的菌丝生长速度快,产孢能力强,摇瓶发酵葡萄糖140小时,平均L-苹果酸产率为72．53g／L,对糖转化率53．74×10^-2。全发酵液经薄层层析测定,不含黄曲霉毒素。发酵产物分离提纯后,得到白色粉末状结晶,经纸层析、质谱及红外光谱测定,证明为L-苹果酸。     

丙氨酸转氨酶修饰对大肠杆菌L-色氨酸合成的影响

探究大肠杆菌细胞内负责L-丙氨酸合成的转氨酶对菌株代谢及L-色氨酸合成的影响。运用Red重组技术分别对编码L-丙氨酸转氨酶的基因alaA、alaC和avtA进行敲除。通过摇瓶和50 L罐中探究其对L-色氨酸积累、L-丙氨酸代谢及菌体生长变化情况。结果显示,除3种L-丙氨酸转氨酶全部缺失的工程菌L-丙氨酸合成受阻、菌体生长受到较强抑制外,其它各任意一种或两种丙氨酸转氨酶缺失菌株的生长并未有较大差异,但色氨酸的合成变化显著。其中alaA和alaC双基因缺失的E.coli FS-T4工程菌,摇瓶发酵L-色氨酸产量达6.08 g/L,L-丙氨酸含量仅0.16 g/L,较出发菌株分别提高了26.7%和降低了91.0%。在50 L罐中E.coli FS-T4工程菌L-色氨酸产量最高可达41.9 g/L,糖酸转化率达20.5%,分别较出发菌株提高了13.8%和5.1%。转氨酶AlaA和AlaC的同时缺失,既可以满足细胞整体氨基酸池的需要,而且有利于减少杂酸的积累,使得更多的碳源流向L-色氨酸的合成。     

β-半乳糖苷酶和阿拉伯糖异构酶共表达一步法催化乳糖到塔格糖

[目的] 构建一株以廉价原料乳糖为底物合成塔格糖的重组菌株,实现一步法高效生物合成稀有糖——塔格糖。[方法] 从Escherichia coli K-12基因组中,PCR扩增出阿拉伯糖异构酶araA和β-半乳糖苷酶lacZ基因,以SD-AS为连接子,利用pET28a-1载体串联表达于Escherichia coli BL21（DE3）,获得重组菌E.coli BL21/pET28a-araA-lacZ,对重组菌全细胞催化合成塔格糖的条件进行了工艺优化与放大研究。[结果] araA和lacZ基因在E.coli BL21中同时高效表达,在最优条件（pH 8.0、温度50℃、5 mmol/L Mn²⁺、添加0.5 mol/L硼酸和0.1% SDS）下,E.coli BL21/pET28a-araA-lacZ全细胞转化100 g/L乳糖,合成塔格糖最高产量达24.03±2.03 g/L,乳糖到塔格糖的摩尔转化率为45.67%,随着底物乳糖浓度的提高,塔格糖产量呈不同程度的提高,当投加500 g/L底物乳糖时,全细胞合成塔格糖产量最高达83.81±1.38 g/L。[结论] 通过2个关键靶酶的编码基因araA和lacZ在E.coli BL21细胞中进行共表达,实现了以重组菌全细胞为催化剂转化廉价底物乳糖,一步法高效合成稀有糖塔格糖,该研究为生物法制备低能量的功能性稀有糖奠定了较好的研究基础。     

特异腐质霉角质酶-OMP25融合蛋白在大肠杆菌中的高效表达

【目的】通过探究特异腐质霉角质酶-OMP25融合蛋白(HiC-OMP25)在不同大肠杆菌(Escherichia coli)菌株中的表达情况、底物降解情况、热稳定性及宿主菌细胞膜通透性与细胞表面疏水性,揭示表达HiC-OMP25时不同宿主菌的差异性,并进一步提高HiC-OMP25在大肠杆菌中的表达量。【方法】分别在E.coli BL21(DE3)及E.coli C43(DE3)中表达HiC-OMP25,并测定其对对硝基苯丁酸酯(4-nitrophenol butyrate,pNPB)、聚丙烯酸乙酯(polyethyl acrylate,PEA)的降解效果、50℃稳定性;测定表达HiC-OMP25时宿主菌的细胞膜通透性及细胞表面疏水性变化;共表达伴侣蛋白提高HiC-OMP25在E.coli C43(DE3)中的表达量。【结果】HiC-OMP25在E.coli BL21(DE3)与E.coli C43(DE3)中均成功表达并降解pNPB,但前者对PEA的降解效果及50 ℃稳定性均低于后者。同时,表达HiC-OMP25显著增强了E.coli BL21(DE3)的细胞膜通透性及细胞表面疏水性。HiC-OMP25与巯基氧化酶(Erv1p)、二硫键异构酶(DsbC)在E.coli C43(DE3)中共表达时,其表达量为原始菌株的2.14倍,且对pNPB及PEA均有良好的降解效果。【结论】异源表达时,HiC-OMP25在E.coli C43(DE3)中正确折叠,而在E.coli BL21(DE3)中未完全正确折叠;通过共表达伴侣蛋白提高了HiC-OMP25在E.coli C43(DE3)中的表达量,为以后HiC-OMP25的工业化生产及应用奠定了基础。     

产γ-氨基丁酸基因工程重组大肠杆菌的构建及其发酵特性

【目的】构建高产γ-氨基丁酸的基因工程重组大肠杆菌（E.coli）,并研究其发酵特性。【方法】首先通过分子生物学方法构建重组质粒pTrc99a-gadB和pTrc99a-gadB-SNO1-SNZ1,然后分别将它们转入基因敲除菌株E.coli ΔgabPΔpuuE/pTrc99a-gadB在含20 g/L底物l-谷氨酸钠的1 L发酵液中的扩大培养结果表明,重组菌培养24 h时,其发酵液中γ-氨基丁酸的含量达到最高值9.4 g/L。【结论】经基因工程构建的重组大肠杆菌产γ-氨基丁酸的能力明显提高,该研究结果为γ-氨基丁酸的产业化生产提供了良好基础。     

基于PKS和NRPS基因的海洋来源抗病原菌活性菌株筛选及其代谢产物活性分析

基于聚酮合成酶基因(polyketide synthases gene,PKS)和非核糖体多肽合成酶基因(non ribosomal polypeptide synthase gene,NRPS),本研究从77株分离于北冰洋海泥的菌株中筛选出1株具有较高抗病原菌活性的菌株并对其进行了菌种鉴定。通过优化培养基组成和发酵条件提高了该菌株活性代谢产物的产量,并利用高分辨率质谱(high resolution mass spectrometry,HRMS)、核磁氢谱(¹H nuclear magnetic hydrogen,¹H NMR)和碳谱(¹³C NMR)对其主要代谢产物进行了结构鉴定。测定了该菌株主要代谢产物的抗菌谱及代谢产物对黄瓜枯萎病的影响。研究结果表明,该菌株为贝莱斯芽孢杆菌(Bacillus velezensis),其对植物具有一定的促生作用。当发酵条件为麦芽糖5g/L、胰蛋白胨10g/L、氯化钠10g/L、温度30℃、转速150r/min、发酵时间60h时,该菌株代谢产物的抑菌圈直径由(16.23±0.42)mm提高至(24.42±0.57)mm。菌株代谢产物含有大环内酯类化合物macrolactin A,其对多种病原细菌和真菌具有明显拮抗作用。黄瓜幼苗实验表明,该菌株代谢产物对黄瓜枯萎病具有防护作用,其作为生防菌剂具有一定的开发应用潜力。     

调控大肠杆菌胞内ATP和NADH水平促进琥珀酸生产

琥珀酸作为一种重要的C4平台化合物,广泛应用于食品、化学、医药等领域。利用大肠杆菌(Escherichia coli)发酵生产琥珀酸受胞内辅因子不平衡的影响,存在产率低、生产强度低、副产物多等问题。为此,对不同氧气条件下琥珀酸产量和化学计量学分析发现,微厌氧条件下E.coli FMME-N-26高效积累琥珀酸需要借助三羧酸循环(tricarboxylic acid cycle,TCA)为还原性三羧酸途径(reductive tricarboxylic acid pathway,r-TCA)提供足够的ATP和NADH。通过减少ATP消耗、强化ATP合成、阻断NADH竞争途径和构建NADH回补路径等代谢工程策略,组合调控胞内ATP与NADH含量,获得工程菌株E.coli FW-17。通过发酵条件优化,菌株E.coli FW-17在5 L发酵罐能积累139.52 g/L琥珀酸,比出发菌株提高了17.81%,乙酸浓度为1.40 g/L,降低了67.59%。进一步在1000 L发酵罐中进行放大实验,琥珀酸产量和乙酸浓度分别为140.2 g/L和1.38 g/L。     

Construction of a heat-inducible Escherichia coli strain for efficient de novo biosynthesis of l-tyrosine

l-Tyrosine is an important amino acid widely used in food, agriculture, and pharmaceutical industries. However, the industrial application was severely constrained due to low production. To obtain the Escherichia coli mutant producing l-tyrosine in abundance, the heat-inducible expression vector carrying the two feedback resistance enzymes (3-deoxy-7-phosphoheptulonate synthase encoded by aroG^fbr and chorismate mutase/prephenate dehydrogenase encoded by tyrA^fbr) were introduced into the phenylalanine-producing E. coli strain to enable it to synthesize l-tyrosine directly from glucose. Furthermore, the CRISPR-Cas9 technology was applied to eliminate l-phenylalanine and l-tryptophan pathways for their competition for the carbon flux. The global regulatory protein TyrR, which mediates the biosynthesis and transportation of aromatic amino acids, was also deleted to increase l-tyrosine production. Among the recombinant strains, the pheA/tyrR double-gene deletion strain had the highest yield of 5.84 g/L on shake flasks. The feeding strategies were then optimized in a 3-L fermentor. The pheA/tyrR double-gene deletion strain with the heat-inducible expression plasmid pAP-aroG^fbr-tyrA^fbr was able to produce 55.54 g/L l-tyrosine by fed-batch fermentation; the substrate conversion rate was 0.25 g/g. The recombinant strains constructed in this study could be an industrial platform for the microbial production of l-tyrosine directly from glucose.     

Engineering Escherichia coli for efficient production of 5-aminolevulinic acid from glucose

5-Aminolevulinic acid (ALA) recently received much attention due to its potential applications in many fields. In this study, we developed a metabolic strategy to produce ALA directly from glucose in recombinant Escherichia coli via the C5 pathway. The expression of a mutated hemA gene, encoding a glutamyl-tRNA reductase from Salmonella arizona, significantly improved ALA production from 31.1 to 176 mg/L. Glutamate-1-semialdehyde aminotransferase from E. coli was found to have a synergistic effect with HemA^M from S. arizona on ALA production (2052 mg/L). In addition, we identified a threonine/homoserine exporter in E. coli, encoded by rhtA gene, which exported ALA due to its broad substrate specificity. The constructed E. coli DALA produced 4.13 g/L ALA in modified minimal medium from glucose without adding any other co-substrate or inhibitor. This strategy offered an attractive potential to metabolic production of ALA in E. coli.     

Metabolic engineering of E. coli for improving mevalonate production to promote NADPH regeneration and enhance acetyl-CoA supply

Microbial production of mevalonate from renewable feedstock is a promising and sustainable approach for the production of value-added chemicals. We describe the metabolic engineering of Escherichia coli to enhance mevalonate production from glucose and cellobiose. First, the mevalonate-producing pathway was introduced into E. coli and the expression of the gene atoB, which encodes the gene for acetoacetyl-CoA synthetase, was increased. Then, the deletion of the pgi gene, which encodes phosphoglucose isomerase, increased the NADPH/NADP⁺ ratio in the cells but did not improve mevalonate production. Alternatively, to reduce flux toward the tricarboxylic acid cycle, gltA, which encodes citrate synthetase, was disrupted. The resultant strain, MGΔgltA-MV, increased levels of intracellular acetyl-CoA up to sevenfold higher than the wild-type strain. This strain produced 8.0 g/L of mevalonate from 20 g/L of glucose. We also engineered the sugar supply by displaying β-glucosidase (BGL) on the cell surface. When cellobiose was used as carbon source, the strain lacking gnd displaying BGL efficiently consumed cellobiose and produced mevalonate at 5.7 g/L. The yield of mevalonate was 0.25 g/g glucose (1 g of cellobiose corresponds to 1.1 g of glucose). These results demonstrate the feasibility of producing mevalonate from cellobiose or cellooligosaccharides using an engineered E. coli strain.     

代谢工程改造大肠杆菌合成丙二酸

丙二酸是一种重要的有机二元羧酸,其应用价值遍及化工、医药、食品等领域。本文以大肠杆菌为底盘细胞,过表达了ppc、aspC、panD、pa0132、yneI和pyc基因,成功构建了丙二酸合成重组菌株大肠杆菌BL21(TPP)。该菌株在摇瓶发酵条件下,丙二酸产量达到0.61 g/L。在5 L发酵罐水平,采用间歇补料的方式丙二酸的积累量达3.32 g/L。本研究应用了融合蛋白技术,将ppc和aspC、pa0132和yneI分别进行融合表达,构建了工程菌BL21(SCR)。在摇瓶发酵水平,该菌株丙二酸的积累量达到了0.83 g/L,较出发菌株BL21(TPP)提高了36%。在5 L发酵罐中,工程菌BL21(SCR)的丙二酸产量最高达5.61 g/L,较出发菌株BL21(TPP)提高了69%。本研究实现了丙二酸在大肠杆菌中的生物合成,为构建丙二酸合成的细胞工厂提供了理论依据和技术基础,同时也对其他二元羧酸的生物合成具有启发和指导意义。     

Pathway engineering of Escherichia coli for α-ketoglutaric acid production

α-Ketoglutaric acid (α-KG) is a multifunctional dicarboxylic acid in the tricarboxylic acid (TCA) cycle, but microbial engineering for α-KG production is not economically efficient, due to the intrinsic inefficiency of its biosynthetic pathway. In this study, pathway engineering was used to improve pathway efficiency for α-KG production in Escherichia coli. First, the TCA cycle was rewired for α-KG production starting from pyruvate, and the engineered strain E. coli W3110Δ4-PCAI produced 15.66 g/L α-KG. Then, the rewired TCA cycle was optimized by designing various strengths of pyruvate carboxylase and isocitrate dehydrogenase expression cassettes, resulting in a large increase in α-KG production (24.66 g/L). Furthermore, acetyl coenzyme A (acetyl-CoA) availability was improved by overexpressing acetyl-CoA synthetase, leading to α-KG production up to 28.54 g/L. Finally, the engineered strain E. coli W3110Δ4-P_(H)CAI_(H)A was able to produce 32.20 g/L α-KG in a 5-L fed-batch bioreactor. This strategy described here paves the way to the development of an efficient pathway for microbial production of α-KG.     

Co‐culture engineering for microbial biosynthesis of 3‐amino‐benzoic acid in Escherichia coli

3‐amino‐benzoic acid (3AB) is an important building block molecule for production of a wide range of important compounds such as natural products with various biological activities. In the present study, we established a microbial biosynthetic system for de novo 3AB production from the simple substrate glucose. First, the active 3AB biosynthetic pathway was reconstituted in the bacterium Escherichia coli, which resulted in the production of 1.5 mg/L 3AB. In an effort to improve the production, an E. coli‐E. coli co‐culture system was engineered to modularize the biosynthetic pathway between an upstream strain and an downstream strain. Specifically, the upstream biosynthetic module was contained in a fixed E. coli strain, whereas a series of E. coli strains were engineered to accommodate the downstream biosynthetic module and screened for optimal production performance. The best co‐culture system was found to improve 3AB production by 15 fold, compared to the mono‐culture approach. Further engineering of the co‐culture system resulted in biosynthesis of 48 mg/L 3AB. Our results demonstrate co‐culture engineering can be a powerful new approach in the broad field of metabolic engineering.     

Metabolic design of a platform Escherichia coli strain producing various chorismate derivatives

A synthetic metabolic pathway suitable for the production of chorismate derivatives was designed in Escherichia coli. An L-phenylalanine-overproducing E. coli strain was engineered to enhance the availability of phosphoenolpyruvate (PEP), which is a key precursor in the biosynthesis of aromatic compounds in microbes. Two major reactions converting PEP to pyruvate were inactivated. Using this modified E.coli as a base strain, we tested our system by carrying out the production of salicylate, a high-demand aromatic chemical. The titer of salicylate reached 11.5 g/L in batch culture after 48 h cultivation in a 2-liter jar fermentor, and the yield from glucose as the sole carbon source exceeded 40% (mol/mol). In this test case, we found that pyruvate was synthesized primarily via salicylate formation and the reaction converting oxaloacetate to pyruvate. In order to demonstrate the generality of our designed strain, we employed this platform for the production of each of 7 different chorismate derivatives. Each of these industrially important chemicals was successfully produced to levels of 1–3 g/L in test tube-scale culture.